skip banner - Return to original view
site viewing options
 
Parents|Medical Information|Professionals|In your area|Campaigns

Histiocytosis

How is it treated?

In time Langerhans Cell Histiocytosis (LCH) may burn itself out, but there may be long-standing problems due to damage caused by the disease process. Not all patients require specific treatment but, when this is indicated, they usually receive corticosteroids (Prednisolone) or cytotoxic drugs.

Haemophagocytic Lymphohistiocytosis (HLH) is often triggered by viral or other infection and improvement generally follows treatment for the precipitating infection and removal of immune suppression, if this is possible. Primary HLH is a genetic disorder which usually presents in very young children with no other known immune abnormality. This group of children usually require drug treatment with corticosteroids, cytotoxic chemotherapy, or the immune suppressive drugs antithymocyte globulin and Cyclosporin. Children with a definite family history (familial HLH) generally receive a bone marrow transplant once the disease is adequately controlled and this is often also necessary for other children with primary HLH who do not have a definite family history.

View What are the causes? What are the causes?  |  Inheritance patterns and prenatal diagnosis View Inheritance patterns and prenatal diagnosis

Medical text written December 1997 by Dr David Webb Consultant Paediatric Haematologist/Oncologist, Great Ormond Street Hospital, London, UK. Last updated September 2006 by Professor Peter Beverley, Institute for Vaccine Research, Newbury, UK.

 

Tell us what you think of this information...

Print whole article Print whole article

 

This Web Site © Copyright, Contact a Family 2008
Contact a Family, 209-211 City Road, London EC1V 1JN
Tel: (020) 7608 8700

Registered Charity No. 284912. Charity registered in Scotland No. SC039169
Company limited by guarantee, registered in England and Wales No. 1633333.
HM Revenue & Customs charity tax reference No. XN54769. VAT Reg. No. GB 749 3846 82